Sodium–glucose cotransporter-2 inhibitor combination therapy to optimize glycemic control and tolerability in patients with type 2 diabetes: focus on dapagliflozin–metformin

Overview of attention for article published in Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, March 2016

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 5 Dimensions

Readers on

mendeley: 59 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 432 followers.

NaGu cotransporter 2 i/r c/n t/y to o/e glycemic c/l & t/y in p/s with T2 dia focus on dapagliflozin metformin. https://t.co/HGoZMnwxgU

Reply Repost Favourite